Published in Virchows Arch B Cell Pathol Incl Mol Pathol on January 01, 1983
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med (2000) 7.54
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia (2006) 5.64
Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas. Oncogene (2000) 2.27
The selective elimination of immunologically competent cells from bone marrow and lymphocyte cell mixtures. 3. In vitro test for detection of immunocompetent cells in fractionated mouse spleen cell suspensions and primate bone marrow suspensions. Transplantation (1969) 1.96
National seasonal influenza vaccination survey in Europe, 2008. Euro Surveill (2008) 1.63
A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin. Clin Exp Immunol (2004) 1.54
Eosinophilic gastroenteritis with ascites: a case report and review of the literature. Dig Dis Sci (2003) 1.51
Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): data from the University Hospital "Maggiore della Carità" in Novara. Endocrine (2012) 1.50
Apocrine carcinoma of the skin. A clinicopathologic, immunocytochemical, and ultrastructural study. Cancer (1993) 1.48
Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas. Lancet (1987) 1.34
Distribution of interferon-gamma receptor in human tissues. Eur J Immunol (1992) 1.30
Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin Endocrinol (Oxf) (2011) 1.25
Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft. Bone Marrow Transplant (2000) 1.19
Pathology of thymic epithelial tumors. Curr Top Pathol (1986) 1.19
Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells. J Biol Chem (1999) 1.18
A new case of reactive arthritis after hepatitis B vaccination. Clin Exp Rheumatol (1993) 1.17
Thymomas. A review of 169 cases, with particular reference to results of surgical treatment. Cancer (1986) 1.11
Detection of immunoglobulin kappa light chain rearrangements by polymerase chain reaction. An improved method for detecting clonal B-cell lymphoproliferative disorders. Am J Pathol (1999) 1.10
Thymic lymphocytes bear a surface antigen which cross-reacts with acetylcholine receptor. Nature (1980) 1.10
Carcinogenicity of dimethylnitrosamine in Swiss mice. Br J Cancer (1966) 1.09
Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1. J Cell Physiol (1997) 1.08
Immunohistological evidences of cortical and medullary differentiation in thymoma. Virchows Arch A Pathol Anat Histopathol (1985) 1.07
Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas. Clin Exp Immunol (2007) 1.05
Forecasting the growth of multicell tumour spheroids: implications for the dynamic growth of solid tumours. Cell Prolif (2000) 1.03
Epidemiology of pleural mesothelioma in North-western Italy (Piedmont). Br J Ind Med (1972) 1.03
Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection. Eur J Immunol (2000) 1.01
In vitro studies of HIV-1 infection in thymic lymphocytes: a putative role of the thymus in AIDS pathogenesis. AIDS Res Hum Retroviruses (1990) 1.00
Thymus-marrow cell interaction evaluated by PHA stimulation and graft versus host activity. Nature (1971) 1.00
A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow. Cancer (1991) 0.99
Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family. Int J Cancer (1999) 0.99
Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood (2000) 0.99
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy. Blood (1999) 0.99
Sonographic appearance of aggressive angiomyxoma of the bladder. J Clin Ultrasound (1999) 0.99
Low coverage of seasonal influenza vaccination in the elderly in many European countries. Euro Surveill (2008) 0.98
Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas. Eur Arch Otorhinolaryngol (1997) 0.97
Myasthenia gravis: immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown. J Neuroimmunol (1986) 0.97
Detection of vascular endothelial growth factor/ vascular permeability factor in periapical lesions. J Endod (2003) 0.96
Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma. Eur J Cancer (2001) 0.96
[Pediatric clinical experimentation with rifampicin. Therapeutic effect and tolerance]. Clin Pediatr (Bologna) (1969) 0.96
Can Ki67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma? J Clin Pathol (1994) 0.96
Specific IgE antibodies in twenty-eight workers with diisocyanate-induced bronchial asthma. Clin Allergy (1984) 0.96
Oscillating growth patterns of multicellular tumour spheroids. Cell Prolif (1999) 0.96
Immunohistochemical evidence of active thymocyte proliferation in thymoma. Its possible role in the pathogenesis of autoimmune diseases. Am J Pathol (1987) 0.95
Signet ring cell lymphoma in salivary gland. An immunohistochemical and ultrastructural study. Appl Pathol (1984) 0.95
Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones. Clin Exp Immunol (2001) 0.94
Bone augmentation of the inferior floor of the maxillary sinus with autogenous bone or composite bone grafts: a histologic-histomorphometric preliminary report. Int J Oral Maxillofac Implants (1998) 0.94
Expansion and molecular evolution of the interferon-induced 2'-5' oligoadenylate synthetase gene family. Mol Biol Evol (2000) 0.94
BRAF gene is not mutated in plasma cell leukemia and multiple myeloma. Leukemia (2003) 0.94
Small bowel metastasis from squamous cell carcinoma of the larynx. A case report. Tumori (1993) 0.93
The complex interplay of the DQB1 and DQA1 loci in the generation of the susceptible and protective phenotype for insulin-dependent diabetes mellitus. Mol Immunol (1994) 0.93
Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular, and solid patterns. Am J Surg Pathol (1993) 0.93
Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients. Ann Oncol (1998) 0.91
Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases. Int J Cancer (2000) 0.91
Angiogenesis: prognostic significance in laryngeal cancer. Anticancer Res (1999) 0.90
Study of ethmoidal mucosa in a population at occupational high risk of sinonasal adenocarcinoma. Acta Otolaryngol (2002) 0.90
Differential effects of tyrosine kinase inhibition in CD69 antigen expression and lytic activity induced by rIL-2, rIL-12, and rIFN-alpha in human NK cells. Cell Immunol (1993) 0.89
Acute HIV-1 infection: clinical and biological study of 12 patients. J Acquir Immune Defic Syndr (1990) 0.89
Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization. Am J Pathol (1996) 0.88
Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature. Br J Cancer (2013) 0.88
True hermaphroditism with XX/XY sex chromosome mosaicism: report of a case. Clin Genet (1976) 0.88
Carrier protein-monensin conjugates: enhancement of immunotoxin cytotoxicity and potential in tumor treatment. Cancer Res (1990) 0.87
MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. J Clin Pathol (1994) 0.87
Sensitivity of human leukemia cells in exponential or stationary growth phase to anti-CD5 immunotoxins. Role of intracellular processing events. J Immunol (1994) 0.87
JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia. J Clin Pathol (2009) 0.87
Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma. Leukemia (2002) 0.87
Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas. J Natl Cancer Inst (1989) 0.86
Constitutive expression of CD69 in interspecies T-cell hybrids and locus assignment to human chromosome 12. Immunogenetics (1992) 0.86
Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index. Histopathology (2004) 0.85
Is transposed skin transformed in major head and neck mucosal reconstruction? Acta Otolaryngol (1995) 0.85
Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin. Br J Cancer (1995) 0.85
Association between Crohn's disease and Conn's syndrome. A report of two cases. Panminerva Med (2005) 0.85
A case of ulcerative jejunoileitis treated with anti tumor necrosis factor-alpha antibodies. Panminerva Med (2005) 0.85
Hepatocellular carcinoma complicating primary sclerosing cholangitis in Crohn's disease. A case report. Minerva Gastroenterol Dietol (2007) 0.85
Paraproteinemic variety of pure red cell aplasia: immunological studies in 1 patient. Acta Haematol (1978) 0.84
The biological reaction to polyethylene wear debris can be related with oxidation of the UHMWPE cups. Chir Organi Mov (2004) 0.84
[Lymphadenopathy caused by Toxoplasma in an intramammary lymph node: role of molecular biology in the diagnosis]. Pathologica (1997) 0.84
The murine homolog of the HIN 200 family, Ifi 204, is constitutively expressed in myeloid cells and selectively induced in the monocyte/macrophage lineage. J Leukoc Biol (1998) 0.84
An atypical verrucous carcinoma of the tongue arising in a patient with oral lichen planus associated with hepatitis C virus infection. Oral Oncol (1997) 0.84
Head and neck metastases of renal cancer after nephrectomy: a report of 2 cases. Tumori (1995) 0.84
[Effect of the age factor on the development of malignant lymphomas and hepatomas in Swiss mice treated with urethane (ethyl carbamate)]. Boll Soc Ital Biol Sper (1964) 0.84
Prognostic factors for head and neck tumor recurrence. Acta Otolaryngol (1995) 0.84
The "Green Channel" of the Veneto region as a model for vaccine safety monitoring in Italy. Vaccine (2005) 0.83
Glomerular cell proliferation in human and experimental glomerulonephritis. Light- and electron-microscopical, and autoradiographic observations. Nephron (1977) 0.83
Muscular cramps: proposals for a new classification. Acta Neurol Scand (2003) 0.83
Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma. Clin Cancer Res (2000) 0.83
Stage II large B-cell lymphoma with sclerosis treated with MACOP-B. Ann Oncol (1992) 0.83
Self-potentiation of ligand-toxin conjugates containing ricin A chain fused with viral structures. J Biol Chem (1995) 0.82
Evidence that a leukocyte type of 12-lipoxygenase is expressed and regulated by angiotensin II in human adrenal glomerulosa cells. Endocrinology (1994) 0.82
Immunophenotype of thymoma-associated lymphoid cell component of T-cell type. A new analytic procedure in keeping with structural heterogeneities. Virchows Arch B Cell Pathol Incl Mol Pathol (1990) 0.82
Peripheral neuropathy associated with immunoglobulin disorders an immunological and ultrastructural study. Acta Neuropathol Suppl (1981) 0.82